Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Australian Sapphire Corp — Sigyn Therapeutics, Inc. insider · InsiderLens

/ / Australian Sapphire Corp

Australian Sapphire Corp

10% owner at Sigyn Therapeutics, Inc. · on record since Feb 9, 2016

Insider trading activity of Australian Sapphire Corp

No transactions on record for Australian Sapphire Corp.

Track record of Australian Sapphire Corp

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Australian Sapphire Corp

Co-insiders of Australian Sapphire Corp

Segelman ChayaSigyn Therapeutics, Inc.
Segelman JosephSigyn Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters